From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Ouzo time for me but a bad bathtime for an AIM CEO tonight

By Tom Winnifrith | Wednesday 15 February 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The ouzo refers to the latest crushing blow for snakeoil salesman Darren Winters. This man has claimed to have fleeced, sorry trained, 500,000 Britons yet still the deadwood press fail to report on our takedown of the charlatan. Pathetic. The bathtime refers to the CEO of Tracsis (TRCS) who claims to listen to bearcast in his bath. I comment on today's trading update. Then it is onto China fraud Jiasen (JSI) and its latest bollocks news signed off by low life Nomad Cairn Financial. And then after an en passant look at Polemos (PLMO) I take a very detailed look at Blenheim Natural Resources (BNR) which is overvalued hype with a bushel of red flags thrown in for good measure. I advise my pal Big Dave Lenigas to take profits and sell and others to do likewise.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:58:36